Newland Pharmaceutical Co.,Ltd. responded to investor inquiries on an interactive platform on October 13th, stating that the company's stock price volatility is influenced by multiple factors. Regarding the lifting of restricted shares, the company emphasized that it will strictly comply with relevant laws and regulations to fulfill its information disclosure obligations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments